(2R,3R,4R,5S)-4-chloro-4-ethenyl-2-(2-methylpropyl)-5-propan-2-yloxolan-3-amine
C13H24ClNO — CID 176612834
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R,3R,4R,5S)-4-chloro-4-ethenyl-2-(2-methylpropyl)-5-propan-2-yloxolan-3-amine
(2R,3R,4R,5S)-4-chloro-4-ethenyl-2-(2-methylpropyl)-5-propan-2-yloxolan-3-amine (PubChem CID 176612834) has the molecular formula C13H24ClNO and a molecular weight of 245.79 g/mol. Its IUPAC name is (2R,3R,4R,5S)-4-chloro-4-ethenyl-2-(2-methylpropyl)-5-propan-2-yloxolan-3-amine.
Molecular Properties
| Compound Name | (2R,3R,4R,5S)-4-chloro-4-ethenyl-2-(2-methylpropyl)-5-propan-2-yloxolan-3-amine |
|---|---|
| PubChem CID | 176612834 |
| Molecular Formula | C13H24ClNO |
| Molecular Weight | 245.79 g/mol |
| Exact Mass | 245.15 |
| IUPAC Name | (2R,3R,4R,5S)-4-chloro-4-ethenyl-2-(2-methylpropyl)-5-propan-2-yloxolan-3-amine |
| SMILES | C=C[C@@]1(Cl)[C@H](N)[C@@H](CC(C)C)O[C@H]1C(C)C |
| InChI | InChI=1S/C13H24ClNO/c1-6-13(14)11(15)10(7-8(2)3)16-12(13)9(4)5/h6,8-12H,1,7,15H2,2-5H3/t10-,11-,12+,13-/m1/s1 |
| InChIKey | RWPNGULGYMSCTG-FVCCEPFGSA-N |
| XLogP | 2.95 |
| TPSA | 35.25 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 16 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 245.79 |
| LogP ≤ 5 | 2.95 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176612834 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.